IP Verse

Abbvie Biotechnology competitive analysis

Explore the latest publications and patents granted to Abbvie Biotechnology, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Abbvie Biotechnology
EP4212515	Jul 19, 2023	Quinazolinones As Parp14 Inhibitors	Intended To Grant
EP3986887	Apr 27, 2022	Targeted Protein Degradation Of Parp14 For Use In Therapy	Request For Examination Was Made

Discover the latest PTAB cases involving Abbvie Biotechnology, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Abbvie Biotechnology
IPR2018-00156	Nov 6, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2018-00002	Oct 2, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-02105	Sep 14, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Terminated-Settled
IPR2017-02106	Sep 14, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Terminated-Settled
IPR2017-01988	Aug 21, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-01987	Aug 21, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-01824	Jul 20, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-01823	Jul 20, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-01008	Mar 2, 2017	COHERUS BIOSCIENCES	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-01009	Mar 2, 2017	COHERUS BIOSCIENCES	ABBVIE BIOTECHNOLOGY	Institution Denied

IP litigation analysis comparing Abbvie Biotechnology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
ABBVIE BIOTECHNOLOGY	-	-	-	22	Non-Active
AMGEN	8	132	8	11	Defensive
COHERUS BIOSCIENCES	-	-	12	1	Highly Aggressive
SANDOZ	114	15	19	-	Highly Aggressive